Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

NeuroSearch discontinues ABT-894 program in diabetic neuropathic pain

Feb. 16, 2009

Torrent claims novel Hsp70 inducers with potential for treating stroke

Feb. 16, 2009

Hydroxyfasudil enhances learning and memory in aged rats

Feb. 13, 2009

Adding methotrexate, methylprednisolone to IFN-beta1a not beneficial in relapsing-remitting MS

Feb. 13, 2009

FDA issues complete response letter for Risperdal Consta

Feb. 13, 2009

Novel gamma-secretase inhibitors developed at Schering-Plough

Feb. 13, 2009

TorreyPines reports positive results from phase I clinical trial of NGX-426 in healthy subjects

Feb. 12, 2009

Alfadolone confers antinociception in rat models of inflammation

Feb. 12, 2009

Winston presents topline civamide patch results

Feb. 11, 2009

Novel mGluR2 ligands for schizophrenia and other disorders disclosed by Pfizer researchers

Feb. 11, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...